Unihealth Consultancy Limited IPO - Review, Valuation & GMP Today

Unihealth Consultancy Limited  - Complete Overview

Founded in 2010, Unihealth Consultancy Limited is a healthcare service provider headquartered in Mumbai, India, with a strong operational presence across several countries in the African Continent.

The company is involved in various business segments, including Medical Centers, Hospitals, Consultancy Services, the Distribution of Pharmaceutical and medical Consumable Products, and Medical Value Travel.

Operating under the 'UMC Hospitals' brand, Unihealth Consultancy runs two multi-speciality facilities, namely UMC Victoria Hospital in Kampala, Uganda, with a capacity of 120 beds, and UMC Zhahir Hospital in Kano, Nigeria, with 80 beds. Additionally, they operate 'Unihealth Medical Centre,' a specialized dialysis facility in Mwanza, Tanzania.

Unihealth Consultancy is currently engaged in Project Management Consultancy Services for the establishment of a Health City with over 300 beds in Undri, Pune, Maharashtra, India, in collaboration with PHRC Lifespaces Organization. The company is also involved in various healthcare consultancy projects in Kenya and Angola.

Unihealth Consultancy exports and distributes pharmaceutical and medical consumable products in Uganda, Tanzania, and Nigeria, and acts as distributors in various African countries for pharmaceutical and consumable manufacturing companies based in India.

A subsidiary of Unihealth Consultancy Limited, Unihealth Pharmaceuticals Private Limited, specializes in procuring and exporting pharmaceutical and medical consumable products. These products are primarily supplied to entities such as Victoria Hospital Limited (a Joint Venture of Unihealth Consultancy Limited) in Uganda, UMC Global Health Limited (another Joint-Venture of Unihealth Consultancy Limited) in Nigeria, and 114 Biohealth Limited (a Subsidiary of Unihealth Consultancy Limited) in Tanzania.

The company's registered office is in India, and it maintains a presence in India, Uganda, Nigeria, Tanzania, Kenya, Zimbabwe, Angola, Ethiopia, Mozambique, and DR Congo.

 

 

What does the company do? 

Unihealth Consultancy Limited is a healthcare service provider based out of Mumbai, India, with a strong operational presence across several countries in the African Continent.

 

IPO Overview 

The Unihealth Consultancy IPO date is scheduled from September 8th to September 12th, 2023, with plans for the SME IPO to be listed on the NSE SME on September 21st, 2023. 

The IPO shares will be priced in the range of ?126 to ?132 per share, and the total issue size for this IPO is ?56.55 Crores. 

For an in-depth IPO review, please continue reading, and to stay informed about upcoming IPOs, be sure to check the dedicated Finowings IPO section.

 

Unihealth Consultancy Limited IPO timetable (Tentative)

EVENTS	DATE
IPO Opening Date	8 September 2023
IPO Closing Date	12 September 2023
IPO Allotment Date	15 September 2023
Refund initiation	18 September 2023
IPO Listing Date	21 September 2023

 

Unihealth Consultancy Limited IPO Details 

IPO Opening & Closing Date	8 September to 12 September 2023
Face Value	Rs.10 Per Share
Issue Price	Rs.126 to Rs.132 per share
Lot Size	1000 Shares
Price of 1 Lot	Rs. 132,000
Issue Size	4,284,000 shares (aggregating up to Rs.56.55 Cr)
Offer for Sale	NA
Fresh Issue	4,284,000 shares (aggregating up to Rs.[.] Cr)
Listing at	NSE SME
Issue Type	Book Built Issue IPO
Registrar	Bigshare Services Pvt. Ltd.

 

Unihealth Consultancy Limited IPO Lot Details 

Minimum Lot Investment (Retail)	1 Lot
Maximum Lot Investment (Retail)	1 Lot
Minimum Lot Investment (HNI)	2 Lot

 

Unihealth Consultancy Limited IPO Reservation

Institutional share Portion	50%
Non-institutional share Portion	15%
Retail share Portion	35%

 

Company Financial

Amount in Lakhs

Period	FY - 21	FY - 22	FY - 23
Total Assets	5838.87	6478.65	7833.32
Total Revenue	2863.51	3792.69	4603.01
PAT	500.89	382.02	768.00
Net Worth	1070.36	1479.17	2612.83
Reserve & Surplus	936.17	1344.98	2612.83
Total Borrowings	3871.05	3801.30	3926.67

 

Revenue Bifurcation based on Business Verticals

(Amount in Lakhs)

Particulars	FY 23	FY 22	FY 21
Medical Centres & Hospitals	3,868.00	3,436.64	2,559.11
Export & Distribution of Pharmaceuticals & Medical Consumables	29.14	138.15	-
Medical Value Travel	-	-	-
Consultancy Services	496.72	108.41	61.67
Total Revenue of Operations	4,393.86	3,683.21	2,620.78
Other Income
Discount Received	1.19	1.18	6.00
Exchange Gain on Transactions	121.28	53.30	82.40
Interest on Loans	49.77	32.75	0.02
Interest on FDR's	6.54	2.48	1.75
Rent Receipts	1.76	2.94	2.94
Insurance Claim	17.88	16.20	8.24
Grants & Charity	-	0.63	1.86
Sundry Balance W/back	8.27	-	104.01
Commission Received	-	-	35.50
Profit on Sale of Fixed Asset	2.37	-	-
Int on Income Tax Refund	0.03	-	-
Other Income	0.07	-	-
Total Other Income	209.15	109.48	242.73
Total Income/Revenue	4,603.01	3,792.69	2,863.51

 

Objective of the Issue 

The company intends to allocate the funds for the following purposes:

• Investment in the joint venture of the company, Victoria Hospital Limited (VHL) in Kampala, Uganda, to support its capital expenditure needs for planned expansion and working capital requirements.
• Investment in the joint venture of the company, UMC Global Health Limited (UMCGHL) in Nigeria, to facilitate its capital expenditure requirements for planned expansion.
• Investment in the subsidiary of the company, Biohealth Limited (BL) in Tanzania, to support its capital expenditure needs for planned expansion.
• Addressing general corporate objectives.

 

Promoters and Management of Unihealth Consultancy Limited 

Dr. Akshay Parmar and Dr. Anurag Shah are the Promoters of the Company.

Pre-issue Promoter shareholding	95.32%
Post-issue Promoter shareholding

 

Peer Comparison 

The Following are the listed peers of the company:

Company Name	Revenue from operations (Rs. in Lakhs)	Diluted EPS (Rs.)	P/E (based on Diluted EPS)
Unihealth Consultancy Limited	4,393.86	6.94	-
KMC Speciality Hospitals (India) Ltd	15,575.6 4	1.64	44.88

 

IPO's Valuations

To assess the IPO valuation, we can utilize the information presented in the company's DRHP. With a share price range of Rs.126 to Rs.132 per share and an EPS of Rs.6.94, if we take the upper end of the price range as the issue price, the company's P/E ratio stands at approximately 19.

 

Dividend Policy

The company has not distributed any dividends in the past, and any potential future dividend payments will be based on the company's financial performance.

 

IPO's Strengths

• A healthcare group led by medical professionals, supported by a highly skilled and experienced professional team.
• Opportunities for growth within current facilities and expansion into related verticals.
• Ongoing investments in advanced medical equipment and the development of new specialities.
• Emphasis on regions where there is a significant supply-demand disparity.
• Established success in consultancy services and operations & management contracts, demonstrating the viability of the concept.

 

IPO Weaknesses

• The company's various businesses are closely intertwined, meaning that a decline in one of its group enterprises could potentially negatively impact the overall company's performance.
• One of the purposes of the IPO is to establish a disposable syringe manufacturing facility in Tanzania, which is a subsidiary of the company, Biohealth Limited. Notably, the promoters lack prior experience in this particular venture.
• The company is currently entangled in legal proceedings.
• The operational activities of the hospital business in Uganda and Nigeria face competition from other hospitals and healthcare providers.
• The company's operations are reliant on securing and maintaining government licenses, which are crucial for the operation of healthcare facilities.
• The business is exposed to fluctuations in foreign exchange rates, which can affect its financial performance.

 

 

IPO GMP Today

The Latest GMP of Unihealth Consultancy SME IPO is Rs.30.

 

Conclusion

The company offers investors an opportunity to invest in the healthcare sector and boasts a solid global presence, with aspirations for further expansion. The company has established strong partnerships between India and Africa. Investors can consider placing their funds in this offering following a thorough analysis.

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

 

To Read the Prospectus of the Company Click Here to Download the RHP

 

 

Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.

 

Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock market.